1. Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Shikonin in Colon Cancer
   Yang Chen et al, 2020, Frontiers in Pharmacology CrossRef
2. Antibacterial Mechanism of Shikonin Against Vibrio vulnificus and Its Healing Potential on Infected Mice with Full-Thickness Excised Skin
   Yifei He et al, 2023, Foodborne Pathogens and Disease CrossRef
3. Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
   Sascha D. Markowitsch et al, 2021, Cancers CrossRef
4. Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway
   Sascha D. Markowitsch et al, 2022, Cancers CrossRef
5. Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
   Jieli Pan et al, 2021, Frontiers in Pharmacology CrossRef
6. Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation
   Tianyu Zhai et al, 2021, Frontiers in Pharmacology CrossRef
7. Anti-cancer Research on Arnebiae radix-derived Naphthoquinone in Recent Five Years
   Shengjun Ma et al, 2022, Recent Patents on Anti-Cancer Drug Discovery CrossRef
8. Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
   Fangfang Wang et al, 2020, Frontiers in Pharmacology CrossRef